Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

1. Garassino, M.C.
2. Gadgeel, S.
3. Esteban, E.
4. Felip, E.
5. Speranza, G.
6. Domine, M.
7. Hochmair, M.J.
8. Powell, S.
9. Cheng, S.Y.-S.
10. Bischoff, H.G.
11. Peled, N.
12. Reck, M.
13. Hui, R.
14. Garon, E.B.
15. Boyer, M.
16. Wei, Z.
17. Burke, T.
18. Pietanza, M.C.
19. Rodríguez-Abreu, D.